Abstract:Background: While the phenotypic association between anti-Müllerian hormoneand age at menopause has been widely studied, the role of anti-Müllerian hormone in predicting the age at menopause is currently controversial, and the genetic architecture or causal relationships underlying these 2 traits is not well understood. Aim: We aimed to explore the shared genetic architecture between anti-Müllerian hormone and age at menopause, to identify shared pleiotropic loci and genes, and to investigate causal association and potential causal mediators. Study design: Using summary statistics from publicly available genome-wide association studies on anti-Müllerian hormone (N=7049) and age at menopause (N=201,323) in Europeans, we investigated the global genetic architecture between anti-Müllerian hormone and age at menopause through linkage disequilibrium score regression. We employed pleiotropic analysis under composite null hypothesis, Functional Mapping and Annotation of Genetic Associations, multimarker analysis of GenoMic annotation, and colocalization analysis to identify loci and genes with pleiotropic effects. Tissue enrichment analysis based on Genotype-Tissue Expression data was conducted using the Linkage Disequilibrium Score for the specific expression of genes analysis. Functional genes that were shared were additionally identified through summary data-based Mendelian randomization. The relationship between anti-Müllerian hormone and age at menopause was examined through 2-sample Mendelian randomization, and potential mediators were further explored using colocalization and metabolite-mediated analysis. Results: A positive genetic association (correlation coefficient=0.88, P=1.33×10-5) was observed between anti-Müllerian hormone and age at menopause. By using pleiotropic analysis under composite null hypothesis and Functional Mapping and Annotation of Genetic Associations, 42 significant pleiotropic loci were identified that were associated with anti-Müllerian hormone and age at menopause, and 10 of these (rs10734411, rs61913600, rs2277339, rs75770066, rs28416520, rs9796, rs11668344, rs403727, rs6011452, and rs62237617) had colocalized loci. Additionally, 245 significant pleiotropic genes were identified by multimarker analysis of GenoMic annotation. Genetic associations between anti-Müllerian hormone and age at menopause were markedly concentrated in various tissues including whole blood, brain, heart, liver, muscle, pancreas, and kidneys. Further, summary data-based Mendelian randomization analysis revealed 9 genes that may have a causative effect on both anti-Müllerian hormone and age at menopause. A potential causal effect of age at menopause on anti-Müllerian hormone was suggested by 2-sample Mendelian randomization analysis, with very-low-density lipoprotein identified as a potential mediator. Conclusion: Our study revealed a shared genetic architecture between anti-Müllerian hormone and age at menopause, providing a basis for experimental investigations and individual therapies to enhance reproductive outcomes. Furthermore, our findings emphasized that relying solely on anti-Müllerian hormone is not sufficient for accurately predicting the age at menopause, and a combination of other factors needs to be considered. Exploring new therapeutics aimed at delaying at the onset of menopause holds promise, particularly when targeting shared genes based on their shared genetic architecture.

Mendelian randomization identifies circulating proteins as biomarkers for age at menarche and age at natural menopause

Metabolome-wide Mendelian randomization for age at menarche and age at natural menopause

Joint Associations Of Actual Age And Genetically Determined Age At Menarche With Risk Of Mortality

A Serum Mirna Profile of Human Longevity: Findings from the Baltimore Longitudinal Study of Aging (BLSA)

Genetic Evidence for Causal Relationships Between Age at Natural Menopause and the Risk of Aging-Associated Adverse Health Outcomes

Dissecting the shared genetic architecture between anti-Müllerian hormone and age at menopause based on genome-wide association study

Association Analyses Suggest Multiple Interaction Effects of the Methylenetetrahydrofolate Reductase Polymorphisms on Timing of Menarche and Natural Menopause in White Women

Joint Genome-Wide Association Analyses Identified 49 Novel Loci for Age at Natural Menopause

Health outcomes of age at menarche in European women: a two-sample Mendelian randomization study

Age at menarche and polycystic ovary syndrome: A Mendelian randomization study

The impact of reproductive factors on the metabolic profile of females from menarche to menopause

Age at first birth, age at menopause, and risk of ovarian cyst: a two-sample Mendelian randomization study

Genetically Determined Plasma Docosahexaenoic Acid Showed a Causal Association with Female Reproductive Longevity-Related Phenotype: A Mendelian Randomization Study

Association Study of the Oestrogen Signalling Pathway Genes in Relation to Age at Natural Menopause

ALOX12 gene is associated with the onset of natural menopause in white women.

Identification of prospective aging drug targets via Mendelian randomization analysis

Exploring the causal relationship between female reproductive traits and frailty: a two-sample mendelian randomization study

Association between body fat distribution and age at menarche: a two sample Mendelian randomization study

Negative Effects of Age at Menarche on Risk of Cardiometabolic Diseases in Adulthood: A Mendelian Randomization Study

Relationship between age at menarche and breast cancer in individuals, as well as in first-degree kin and estrogen receptor status: a Mendelian randomization study

Genetic Prediction of Osteoporosis by Anti-Müllerian Hormone Levels and Reproductive Factors in Women: A Mendelian Randomization Study